Fig. 6From: Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemiaELIANA trial data (1.5 years) with low (pessimistic) and high (optimistic) curves evaluating ‘stability’ and expert informationBack to article page